For example a molecular genetic testing for SCA1, SCA3, SCA 4, SCA8, SCA18 and SCA25 should be considered for an individual with cerebellar ataxia and peripheral neuropathy. This evidence concerns the gene PNPT1 and peripheral neuropathy.